Pasithea amends 8-K to extend deadline for Alpha-5 Integrin financials filing

Pasithea Therapeutics Corp.

Original 8-K filed June 22, 2022 reported acquisition of Alpha-5 Integrin, LLC.
This amendment confirms intent to file acquired company financials within 75 days from June 21, 2022.
Pro forma financial information will also be filed within the same period.
No other changes were made to the original Form 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.